The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGooch & Housego Regulatory News (GHH)

Share Price Information for Gooch & Housego (GHH)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 564.00
Bid: 560.00
Ask: 568.00
Change: 4.00 (0.71%)
Spread: 8.00 (1.429%)
Open: 560.00
High: 568.00
Low: 560.00
Prev. Close: 560.00
GHH Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Acquisition and Trading Update

1 Apr 2011 07:00

RNS Number : 0842E
Gooch & Housego PLC
01 April 2011
 



 

For immediate release

 1 April 2011

 

 

Gooch & Housego PLC

("G&H" or the "Company")

 

Acquisition of Crystal Technology, LLC and Trading Update

 

 

Acquisition

 

Gooch & Housego PLC, the specialist manufacturer of optical components and systems, today announces that it has acquired Crystal Technology, LLC, (Crystal Technology) a Palo Alto, California, based manufacturer of acousto-optic, electro-optic and fibre optic components and systems, and oxide single crystal materials for optical applications, for a total consideration of $13.75 million (approximately £8.6 million) comprising $9.625 million for the business and $4.125 million in respect of near cash equivalents being left in the business upon sale. The consideration is payable in two tranches with $10.5 million payable in cash on completion and a further $3.25 million on 31st March 2012. Crystal Technology will be integrated with the Company's existing acousto-optic, electro-optic and fibre optic operations, significantly enhancing G&H's already strong presence in these sectors.

 

Comprising those parts of the business of Crystal Technology, Inc. with applications in acousto-optics, electro-optics and fibre optics, the product range of Crystal Technology is highly complementary to that of G&H. G&H is the leading manufacturer of acousto-optic Q-switches, which are primarily manufactured from silica and glass materials, while Crystal Technology specialises in non-Q-switch acousto-optic devices that are manufactured predominantly from tellurium dioxide, an oxide single crystal material. While Crystal Technology has a capability in Q-switches and G&H has become active in tellurium dioxide devices in recent years, there is limited overlap in terms of products and customers. Crystal Technology's leadership in tellurium dioxide products can in part be attributed to its ability to grow some of the best crystals available anywhere in the world. The strategic importance of this material is such that G&H had begun to develop its own crystal growth capability, but this acquisition will enable G&H to become self-sufficient in tellurium dioxide crystals.

 

Crystal Technology will continue to operate from the existing, leased facility in Palo Alto and approximately 65 people will transfer with the business, including the senior management team. All of the manufacturing and test equipment and other assets necessary to operate the business at current levels are included with the business.

 

Crystal Technology serves a global customer base (approximately two thirds of revenues are derived from outside the USA) operating in sectors spanning industrial, semiconductor, telecommunications, life sciences and defence applications. As a subset of a larger business Crystal Technology has not historically produced stand alone audited accounts, but revenues for the product lines being acquired by G&H for the year to 31st March 2011 are expected to be $17.0 million. The top ten customers account for approximately two thirds of revenues.

 

The acquisition is being funded through a combination of cash and new bank debt provided by the Company's bankers, Royal Bank of Scotland. The Company has taken this opportunity to put in place a new, four year facility comprising an $8 million working capital facility plus an $18 million term loan and a £3.1 million term loan, both of which will be drawn. In addition G&H will have an undrawn capital expenditure facility of a further $8 million.

 

Trading Update

 

Market conditions remain favourable, as reported at our AGM on 23 February, and trading, supported by a strong order book, has continued ahead of management expectations. The integration of EM4, Inc. is progressing to plan as a number of opportunities to supply customers with complex solutions incorporating both active and passive fibre optic components are developed.

 

 

Gareth Jones, Chief Executive of Gooch & Housego commented: -

 

"The acquisition of Crystal Technology consolidates Gooch & Housego's global leadership in the field of acousto-optics and provides self-sufficiency in the strategically important crystals that are central to several of our most exciting new products. In addition to excellent people and top quality products Crystal Technology also brings new capabilities in electro-optics and fibre optics to G&H that support our ongoing diversification into markets such as Defence, Life Sciences and Telecommunications."

 

For further information please contact:

Gareth Jones/Andrew Boteler, 01460 256440

Tim Thompson/Chris McMahon, Buchanan Communications Ltd, 020 7466 5000

Patrick Robb, Investec Bank plc, 020 7597 5970

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAEDFDAXFEAF
Date   Source Headline
4th Apr 20247:00 amRNSHalf Year Trading Update
18th Mar 20242:36 pmRNSDivestment of EM4
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
27th Feb 20243:26 pmRNSNotification of Major Holdings
22nd Feb 20244:07 pmRNSNotification of Major Holdings
21st Feb 202412:31 pmRNSResult of AGM
21st Feb 202410:28 amRNSDirector/PDMR Shareholding
21st Feb 20249:43 amRNSDirector/PDMR Shareholding
21st Feb 20247:00 amRNSAGM Trading Update
12th Jan 20247:00 amRNSAnnual Report and Notice of AGM
10th Jan 20247:00 amRNSGrant of LTIP Awards
9th Jan 202411:53 amRNSNotification of Major Holdings
8th Jan 20243:57 pmRNSNotification of Major Holdings
4th Jan 20243:20 pmRNSDirector/PDMR Shareholding
5th Dec 20237:00 amRNSResults for the year ended 30 September 2023
8th Nov 20237:00 amRNSNotification of Full Year Results
23rd Oct 20232:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSFull Year Trading Update
2nd Oct 20232:44 pmRNSHolding(s) in Company
9th Aug 20236:15 pmRNSDirector/PDMR Shareholding
31st Jul 20238:22 amRNSHolding(s) in Company
21st Jul 202311:58 amRNSCompletion of Acquisition and Issue of Equity
19th Jul 20237:00 amRNSAcquisition of Artemis Optical
23rd Jun 20234:11 pmRNSHolding(s) in Company
21st Jun 202310:26 amRNSDirector/PDMR Shareholding
20th Jun 20236:00 pmRNSAcquisition of GS Optics
6th Jun 20237:00 amRNSInterim Results
23rd May 20237:00 amRNSNotification of Half Year Results
3rd May 20238:56 amRNSIssue of Equity
4th Apr 20237:00 amRNSHalf Year Trading Update
30th Mar 20239:33 amRNSHolding(s) in Company
15th Mar 202312:00 pmRNSAppointment of Non-Executive Director
3rd Mar 20234:37 pmRNSHolding(s) in Company
2nd Mar 20231:10 pmRNSHolding(s) in Company
1st Mar 20239:44 amRNSHolding(s) in Company
22nd Feb 20231:50 pmRNSResult of AGM
22nd Feb 20237:00 amRNSAGM Trading Update
8th Feb 202312:59 pmRNSHolding(s) in Company
9th Jan 202311:44 amRNSGrant of LTIP Awards
21st Dec 202210:02 amRNSPosting of Annual Report and Notice of AGM
20th Dec 202212:30 pmRNSDirector/PDMR Shareholding
6th Dec 20224:26 pmRNSDirector/PDMR Shareholding
6th Dec 20229:38 amRNSDirector/PDMR Shareholding
6th Dec 20227:00 amRNSResults for the year ended 30 September 2022
25th Nov 20223:17 pmRNSHolding(s) in Company
23rd Nov 20224:27 pmRNSHolding(s) in Company
18th Nov 20222:20 pmRNSHolding(s) in Company
2nd Nov 20227:00 amRNSNotification of Full Year Results
27th Oct 202212:56 pmRNSHolding(s) in Company
18th Oct 20222:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.